285 related articles for article (PubMed ID: 4744607)
21. Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients.
Brice P; Bastion Y; Divine M; Nedellec G; Ferrant A; Gabarre J; Reman O; Lepage E; Fermé C
Cancer; 1996 Sep; 78(6):1293-9. PubMed ID: 8826953
[TBL] [Abstract][Full Text] [Related]
22. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
Akhtar S; El Weshi A; Abdelsalam M; Hussaini H; Janabi I; Rahal M; Maghfoor I
Bone Marrow Transplant; 2007 Oct; 40(7):651-8. PubMed ID: 17660837
[TBL] [Abstract][Full Text] [Related]
23. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM
J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714
[TBL] [Abstract][Full Text] [Related]
24. [Treatment of Hodgkin's disease in stages 3 B and IV with the chemotherapy-radiotherapy-chemotherapy sequence].
Amiel JL; Mathé G; Tubiana M; Schlumberger JR; Rouëssé J; Pouillart P
Bull Cancer; 1971; 58(2):191-202. PubMed ID: 4259048
[No Abstract] [Full Text] [Related]
25. [Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
Arranz R; Gil-Fernández JJ; Muñoz E; Acevedo A; Sobrino MP; Fernández-Rañada JM
Sangre (Barc); 1998 Jun; 43(3):179-84. PubMed ID: 9741222
[TBL] [Abstract][Full Text] [Related]
26. [New trends in the treatment of Hodgkin's disease].
Maisin H; Braeken G; Longueville J; Wambersie A; Deckers C
Rev Med Liege; 1973 Jun; 28(12):405-20. PubMed ID: 4732146
[No Abstract] [Full Text] [Related]
27. [Prognostic factors and their importance in the modification of therapeutic approaches in patients with Hodgkin's disease].
Vernerová E; Tesarová P; Hermanská Z; Dienstbier Z; Chytrý P
Cas Lek Cesk; 1993 May; 132(9):266-9. PubMed ID: 8513472
[TBL] [Abstract][Full Text] [Related]
28. Hodgkin's disease: survival and relapse-free data.
Smithers DW
Natl Cancer Inst Monogr; 1973 May; 36():509-12. PubMed ID: 4744606
[No Abstract] [Full Text] [Related]
29. Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma.
Eich HT; Müller RP
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():16-8. PubMed ID: 18167000
[No Abstract] [Full Text] [Related]
30. International Symposium on Hodgkin's Disease. Session 6. Survival data and prognosis. Criteria of cure: clinical-pathological correlations.
Rappaport H; Strum SB
Natl Cancer Inst Monogr; 1973 May; 36():567-9. PubMed ID: 4744611
[No Abstract] [Full Text] [Related]
31. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
Yildiz F; Zengin N; Engin H; Güllü I; Barista I; Caglar M; Ozyar E; Cengiz M; Gürkaynak M; Zorlu F; Caner B; Atahan IL; Tekuzman G
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):839-46. PubMed ID: 15465201
[TBL] [Abstract][Full Text] [Related]
32. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
Petera J; Macharová H; Pohanková R; Malír A; Coupek P; Konecný M; Patera J; Pecina J; Drbal J; Koukalová H; Vásová I
Neoplasma; 2000; 47(2):129-32. PubMed ID: 10985481
[TBL] [Abstract][Full Text] [Related]
33. Verification and comparison of two different predictive equations in Hodgkin's disease.
Bettini R; Tonolini M; Maccianti E
Haematologica; 1997; 82(3):324-7. PubMed ID: 9234580
[TBL] [Abstract][Full Text] [Related]
34. [Results of radiotherapy in Hodgkin's disease (1958-1968)].
Pemsel HK; Hess F; Buchelt L; Pfab R
Strahlentherapie; 1973 Sep; 146(3):251-8. PubMed ID: 4778515
[No Abstract] [Full Text] [Related]
35. Patterns of Hodgkin's disease at diagnosis in young children.
White L; McCourt BA; Isaacs H; Siegel SE; Stowe SM; Higgins GR
Am J Pediatr Hematol Oncol; 1983; 5(3):251-7. PubMed ID: 6625107
[TBL] [Abstract][Full Text] [Related]
36. Hodgkin's disease in Sheffield (1971--76) (with computer analysis of variables).
Hancock BW; Aitken M; Martin JF; Dunsmore IR; Ross CM; Carr I; Emmanuel IG
Clin Oncol; 1979 Dec; 5(4):283-97. PubMed ID: 519913
[No Abstract] [Full Text] [Related]
37. Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
Campbell B; Wirth A; Milner A; Di Iulio J; MacManus M; Ryan G
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1538-45. PubMed ID: 16125872
[TBL] [Abstract][Full Text] [Related]
38. Progress report. Hodgkin's clinical trial, 1972.
Hutchison GB
Natl Cancer Inst Monogr; 1973 May; 36():387-93. PubMed ID: 4582997
[No Abstract] [Full Text] [Related]
39. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I
Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
[TBL] [Abstract][Full Text] [Related]
40. [The significance of mediastinal involvement and other risk factors for survival in patients with Hodgkin's disease].
Melínova L; Hermanská Z; Halíková J; Dienstbier Z; Vacková B; Zámecník J; Skala E
Vnitr Lek; 1995 May; 41(5):307-12. PubMed ID: 7653060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
